Successful treatment of Stenotrophomonas maltophilia with ceftazidime-avibactam and aztreonam in an individual with cystic fibrosis: A case report

被引：0
|
作者：
Duehlmeyer, Stephanie [1 ]
Meier, Ellen [1 ]
Oermann, Christopher [1 ]
机构：
[1] Childrens Mercy Kansas City, Kansas City, MO 64108 USA
来源：
PEDIATRIC PULMONOLOGY | 2025年 / 60卷 / 01期
关键词：
cystic fibrosis; pulmonary exacerbation; stenotrophomonas maltophilia;
D O I：
10.1002/ppul.27363
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Treatment of a challenging NDM and OXA-48-producing Klebsiella pneumoniae causing skin and soft tissue infection and exhibiting resistance to the combination of Ceftazidime-Avibactam and Aztreonam: A case report
    Almangour, Thamer A.
    Aldajani, Ghaida A.
    Alhijji, Ali
    Alsharidi, Aynaa
    IDCASES, 2024, 37
  • [32] A COMPARISON OF AZTREONAM AND CEFTAZIDIME IN THE TREATMENT OF RESPIRATORY-INFECTIONS IN ADULTS WITH CYSTIC-FIBROSIS
    SALH, B
    BILTON, D
    DODD, M
    ABBOT, J
    WEBB, K
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1992, 24 (02) : 215 - 218
  • [33] ANTIMICROBIAL ACTIVITY OF CEFTAZIDIME-AVIBACTAM AND COMPARATOR AGENTS AGAINST PSEUDOMONAS AERUGINOSA AND ENTEROBACTERALES CAUSING PNEUMONIA IN CYSTIC FIBROSIS PATIENTS
    Duncan, L. R.
    Streit, J. M.
    Castanheira, M.
    Sader, H. S.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S162 - S162
  • [34] In vitro activity of ceftolozane-tazobactam and ceftazidime-avibactam against Pseudomonas aeruginosa isolated from patients with cystic fibrosis
    Nolan, Patrick J.
    Jain, Raksha
    Cohen, Leah
    Finklea, James D.
    Smith, Tiffeny T.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2021, 99 (02)
  • [35] Successful treatment of KPC-MDR septic shock with ceftazidime-avibactam in a pediatric critically ill patient
    Vargas, Maria
    Buonomo, Antonio Riccardo
    Buonanno, Pasquale
    Iacovazzo, Carmine
    Servillo, Giuseppe
    IDCASES, 2019, 18
  • [36] In Vitro Susceptibility of Burkholderia cepacia Complex Isolated from Cystic Fibrosis Patients to Ceftazidime-Avibactam and Ceftolozane-Tazobactam
    Van Dalem, A.
    Herpol, M.
    Echahidi, F.
    Peeters, C.
    Wybo, I.
    De Wachter, E.
    Vandamme, P.
    Pierard, D.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (09)
  • [37] Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Determine Optimal Dosing of Ceftazidime-Avibactam for the Treatment of Acute Pulmonary Exacerbations in Patients with Cystic Fibrosis
    Bensman, Timothy J.
    Wang, Joshua
    Jayne, Jordanna
    Fukushima, Lynn
    Rao, Adupa P.
    D'Argenio, David Z.
    Beringer, Paul M.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (10)
  • [38] Carbapenem-Resistant Klebsiella pneumoniae Osteomyelitis Treated with Ceftazidime-Avibactam in an Infant: A Case Report
    Ji, Zejuan
    Sun, Keming
    Li, Zhenwei
    Cheng, Weyland
    Yang, Junwen
    INFECTION AND DRUG RESISTANCE, 2021, 14 : 3109 - 3113
  • [39] Case report: Continuous infusions of ceftazidime-avibactam and aztreonam in combination through elastomeric infusors for 12 weeks for the treatment of bone and joint infections due to metallo-β-lactamase producing Enterobacterales
    Merad, Yanis
    Conrad, Anne
    Brosset, Sophie
    Schmidt, Axel
    Hanriat, Camille
    Lustig, Sebastien
    Laurent, Frederic
    Kolenda, Camille
    Roussel-Gaillard, Tiphaine
    Batailler, Cecile
    Ferry, Tristan
    FRONTIERS IN MEDICINE, 2023, 10
  • [40] Aztreonam plus ceftazidime-avibactam as treatment of NDM-1-producing Klebsiella pneumoniae bacteraemia in a neutropenic patient: Last resort therapy?
    Bocanegra-Ibarias, Paola
    Camacho-Ortiz, Adrian
    Garza-Gonzalez, Elvira
    Flores-Trevino, Samantha
    Kim, Hyojin
    Perez-Alba, Eduardo
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2020, 23 : 417 - 419
12345